Why Jin Medical International Ltd.’s (ZJYL) Stock Is Down 11.04%

By Omar Beirat
July 31, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Jin Medical International Ltd. before investing.

In this article, we go over a few key elements for understanding Jin Medical International Ltd.’s stock price such as:

  • Jin Medical International Ltd.’s current stock price and volume
  • Why Jin Medical International Ltd.’s stock price changed recently
  • Upgrades and downgrades for ZJYL from analysts
  • ZJYL’s stock price momentum as measured by its relative strength

About Jin Medical International Ltd. (ZJYL)

Before we jump into Jin Medical International Ltd.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. It operates in the Mainland China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. operates as a subsidiary of Jolly Harmony Enterprises Limited.

Want to learn more about Jin Medical International Ltd.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Jin Medical International Ltd..

Learn More About A+ Investor

Jin Medical International Ltd.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Jin Medical International Ltd.’s stock price was $1.980.

Jin Medical International Ltd. is up 3.66% from its previous closing price of $1.910.

During the last market session, Jin Medical International Ltd.’s stock traded between $1.930 and $2.100. Currently, there are approximately 7.83 million shares outstanding for Jin Medical International Ltd..

Jin Medical International Ltd.’s price-earnings (P/E) ratio is currently at 13.6, which is low compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Jin Medical International Ltd. Stock Price History

Jin Medical International Ltd.’s (ZJYL) price is currently up 8.79% so far this month.

During the month of July, Jin Medical International Ltd.’s stock price has reached a high of $2.540 and a low of $1.800.

Over the last year, Jin Medical International Ltd. has hit prices as high as $17.184 and as low as $1.641. Year to date, Jin Medical International Ltd.’s stock is down 55%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Jin Medical International Ltd. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded Jin Medical International Ltd.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Jin Medical International Ltd.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Jin Medical International Ltd.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Jin Medical International Ltd.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Jin Medical International Ltd. (ZJYL) by visiting AAII Stock Evaluator.

Relative Price Strength of Jin Medical International Ltd.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Jin Medical International Ltd. has a weighted four-quarter relative price strength of -30.20%, which translates to a Momentum Score of 7 and is considered to be Very Weak.

Want to learn more about how Jin Medical International Ltd. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Jin Medical International Ltd. Stock Price: Bottom Line

As of July 31, 2026, Jin Medical International Ltd.’s stock price is $1.980, which is up 3.66% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Jin Medical International Ltd. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.